IE64514B1
(en)
*
|
1989-05-23 |
1995-08-09 |
Zeneca Ltd |
Azaindenes
|
US5223499A
(en)
*
|
1989-05-30 |
1993-06-29 |
Merck & Co., Inc. |
6-amino substituted imidazo[4,5-bipyridines as angiotensin II antagonists
|
EP0415886A3
(en)
*
|
1989-08-30 |
1991-10-23 |
Ciba-Geigy Ag |
Aza compounds
|
IE70593B1
(en)
*
|
1989-09-29 |
1996-12-11 |
Eisai Co Ltd |
Biphenylmethane derivative the use of it and pharmacological compositions containing same
|
US5250554A
(en)
*
|
1989-10-24 |
1993-10-05 |
Takeda Chemical Industries, Ltd. |
Benzimidazole derivatives useful as angiotensin II inhibitors
|
US5449682A
(en)
*
|
1990-02-13 |
1995-09-12 |
Merck & Co., Inc. |
Angiotensin II antagonists incorporating a substituted benzyl element
|
DE122007000050I1
(de)
*
|
1990-02-19 |
2007-11-08 |
Novartis Ag |
Acylverbindungen
|
US5194379A
(en)
*
|
1990-05-11 |
1993-03-16 |
Merck & Co., Inc. |
Microbial transformation process for the preparation of hydroxylanol imidazo (4,5-b) pyridines useful as angiotensin II receptor antagonists
|
CA2041763A1
(en)
|
1990-05-11 |
1991-11-12 |
Sheih-Shung T. Chen |
Microbial transformation process for antihypertensive products
|
JPH04235974A
(ja)
|
1990-06-08 |
1992-08-25 |
Roussel Uclaf |
新規なイミダゾール誘導体、それらの製造法、得られる新規な中間体、それらの薬剤としての使用及びそれらを含有する製薬組成物
|
WO1991019715A1
(en)
*
|
1990-06-15 |
1991-12-26 |
G.D. Searle & Co. |
1H-SUBSTITUTED-IMIDAZO[4,5-d]PYRIDAZINE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS
|
CA2044806A1
(en)
*
|
1990-07-18 |
1992-01-19 |
Roland Jaunin |
Purine derivatives
|
CA2047029A1
(en)
*
|
1990-07-19 |
1992-01-20 |
Shieh-Shung T. Chen |
Microbial transformation process for antihypertensive products
|
EP0470543A1
(de)
*
|
1990-08-10 |
1992-02-12 |
Dr. Karl Thomae GmbH |
Heterocyclische Imidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zur ihrer Herstellung
|
IE70217B1
(en)
*
|
1990-08-15 |
1996-10-30 |
British Bio Technology |
Benzimidazole derivatives process for their preparation and application
|
IE912874A1
(en)
*
|
1990-08-15 |
1992-02-26 |
British Bio Technology |
Compounds
|
ATE159251T1
(de)
*
|
1990-08-29 |
1997-11-15 |
Upjohn Co |
Tropolonderivate und pharmazeutische zubereitungen davon zur vorbeugung und behandlung von ischämischen krankheiten
|
US5703071A
(en)
*
|
1990-08-29 |
1997-12-30 |
Pharmacia & Upjohn Company |
Tropolone derivatives and pharmaceutical composition thereof for preventing and treating ischemic diseases
|
WO1992004343A1
(en)
*
|
1990-09-04 |
1992-03-19 |
Yamanouchi Pharmaceutical Co., Ltd. |
Novel tetrahydrobenzazole derivative
|
US5091390A
(en)
*
|
1990-09-20 |
1992-02-25 |
E. I. Du Pont De Nemours And Company |
Treatment of CNS disorders with 4,5,6,7-tetrahydro-1H-imidazo (4,5-)-pyridines and analogs
|
US5210092A
(en)
*
|
1990-09-25 |
1993-05-11 |
Fujisawa Pharmaceutical Co., Ltd. |
Angiotensin ii antagonizing heterocyclic derivatives
|
US5470975A
(en)
*
|
1990-10-16 |
1995-11-28 |
E.R. Squibb & Sons, Inc. |
Dihydropyrimidine derivatives
|
AU9024591A
(en)
*
|
1990-10-25 |
1992-05-26 |
G.D. Searle & Co. |
Biphenylalkyl xanthine compounds for treatment of cardiovascular disorders
|
US5124335A
(en)
*
|
1991-01-30 |
1992-06-23 |
Merck & Co., Inc. |
Substituted pyrollo-fused 6 membered heterocycles as angiotensin ii antagonists
|
SI9210098B
(sl)
*
|
1991-02-06 |
2000-06-30 |
Dr. Karl Thomae |
Benzimidazoli, zdravila, ki te spojine vsebujejo, in postopek za njihovo pripravo
|
US5472967A
(en)
*
|
1991-02-20 |
1995-12-05 |
Synthelabo |
4-pyrimidinone derivatives their preparation and their application in therapy
|
US5616599A
(en)
*
|
1991-02-21 |
1997-04-01 |
Sankyo Company, Limited |
Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use
|
EP0502575A1
(en)
*
|
1991-03-06 |
1992-09-09 |
Merck & Co. Inc. |
Substituted 1-(2H)-isoquinolinones
|
CA2062558A1
(en)
*
|
1991-03-08 |
1992-09-09 |
Prasun K. Chakravarty |
Heterocyclic compounds bearing acidic functional groups as angiotensin ii antagonists
|
EP0503838A3
(en)
*
|
1991-03-08 |
1992-10-07 |
Merck & Co. Inc. |
Heterocyclic compounds bearing acidic functional groups as angiotensin ii antagonists
|
US5236928A
(en)
*
|
1991-03-19 |
1993-08-17 |
Merck & Co., Inc. |
Imidazole derivatives bearing acidic functional groups at the 5-position, their compositions and methods of use as angiotensin II antagonists
|
US5187179A
(en)
*
|
1991-03-22 |
1993-02-16 |
Merck & Co., Inc. |
Angiotensin II antagonists incorporating a substituted imidazo [1,2-b][1,2,4]triazole
|
US5128327A
(en)
*
|
1991-03-25 |
1992-07-07 |
Merck & Co., Inc. |
Angiotensin II antagonists incorporating a nitrogen containing six membered ring heterocycle
|
US5177074A
(en)
*
|
1991-03-26 |
1993-01-05 |
Merck & Co., Inc. |
Angiotensin ii antagonists incorporating a substituted thiophene or furan
|
US5798364A
(en)
*
|
1992-03-26 |
1998-08-25 |
Merck Patent Gesellschaft Mit Beschrankter Haftung |
Imidazopyridines
|
DE4110019C2
(de)
*
|
1991-03-27 |
2000-04-13 |
Merck Patent Gmbh |
Imidazopyridine, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
|
US5164403A
(en)
*
|
1991-04-05 |
1992-11-17 |
G. D. Searle & Co. |
N-arylheteroarylalkyl imidazol-2-one compounds for treatment of circulatory disorders
|
US5151435A
(en)
*
|
1991-04-08 |
1992-09-29 |
Merck & Co., Inc. |
Angiotensin ii antagonists incorporating an indole or dihydroindole
|
TW274551B
(hu)
*
|
1991-04-16 |
1996-04-21 |
Takeda Pharm Industry Co Ltd |
|
US5252574A
(en)
*
|
1991-04-26 |
1993-10-12 |
Merck & Co., Inc. |
Angiotensin II antagonists incorporating a substituted thiophene or furan
|
WO1992020662A1
(en)
*
|
1991-05-10 |
1992-11-26 |
Merck & Co., Inc. |
Acidic aralkyl triazole derivatives active as angiotensin ii antagonists
|
US5198438A
(en)
*
|
1991-05-07 |
1993-03-30 |
Merck & Co., Inc. |
Angiotensin ii antagonists incorporating a substituted thiophene or furan
|
JPH05112533A
(ja)
*
|
1991-05-08 |
1993-05-07 |
Upjohn Co:The |
イミダゾベンゾキノン類およびこれを有効成分とする高血圧・鬱血性心不全の予防・治療剤
|
US5506361A
(en)
*
|
1991-05-08 |
1996-04-09 |
Theupjohn Company |
Imidazobenzoquinones and composition for preventing or treating hypertension or congestive heart failure containing the same
|
US5162340A
(en)
*
|
1991-05-10 |
1992-11-10 |
Merck & Co., Inc. |
Substituted 1-(2h)-isoquinolinones bearing acidic functional groups as angiotensin ii antagonists
|
US5436259A
(en)
*
|
1991-05-10 |
1995-07-25 |
Merck & Co., Inc. |
Substituted 1,2,4-triazolin-3-one compounds bearing acidic functional groups as balanced angiotensin II antagonists
|
MX9202300A
(es)
*
|
1991-05-16 |
1992-11-01 |
Glaxo Group Ltd |
Derivados de benzofurano, procedimiento para su preparacion y composicion farmaceutica que los contiene.
|
AU1625192A
(en)
*
|
1991-05-31 |
1992-12-03 |
Zeneca Limited |
Heterocyclic derivatives
|
US5175164A
(en)
*
|
1991-06-05 |
1992-12-29 |
Merck & Co., Inc. |
Angiotensin ii antagonists incorporating a substituted indole or dihydroindole
|
GB9113628D0
(en)
*
|
1991-06-25 |
1991-08-14 |
Ici Plc |
Heterocyclic derivatives
|
GB9113626D0
(en)
*
|
1991-06-25 |
1991-08-14 |
Ici Plc |
Heterocyclic compounds
|
WO1993003033A1
(en)
*
|
1991-07-26 |
1993-02-18 |
G. D. Searle & Co. |
CARBONATE-SUBSTITUTED IMIDAZO[4,5-d] PYRIDAZINE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS
|
US5332750A
(en)
*
|
1991-09-04 |
1994-07-26 |
Merck Patent Gesellschaft Mit Beschrankter Haftung |
1,2-dihydro-2-oxopyridines
|
CA2077419C
(en)
*
|
1991-09-10 |
1998-08-25 |
Yasushi Honma |
Imidazopyridine derivatives and process for preparation thereof
|
US5354759A
(en)
*
|
1991-09-12 |
1994-10-11 |
Fujisawa Pharmaceutical Co., Ltd. |
Angiotenin II antagonizing heterocyclic compounds
|
GB9201789D0
(en)
*
|
1992-01-28 |
1992-03-11 |
Fujisawa Pharmaceutical Co |
Heterocyclic derivatives
|
TW300219B
(hu)
*
|
1991-09-14 |
1997-03-11 |
Hoechst Ag |
|
CA2079982A1
(en)
*
|
1991-10-07 |
1993-04-08 |
Stephen E. De Laszlo |
Substituted pyrazino (2,3-d)-pyrimidinones as angiotensin ii antagonists
|
US5187159A
(en)
*
|
1991-10-07 |
1993-02-16 |
Merck & Co., Inc. |
Angiotensin II antagonists incorporating a substituted 1,3-benzodioxole or 1,3-benzodithiole
|
GB9121727D0
(en)
*
|
1991-10-14 |
1991-11-27 |
Ici Plc |
Heterocyclic compounds
|
US5442062A
(en)
*
|
1991-10-24 |
1995-08-15 |
The Upjohn Company |
Imidazole derivatives and pharmaceutical compositions containing the same
|
FR2683819B1
(fr)
*
|
1991-10-28 |
1994-02-11 |
Synthelabo |
Derives de quinoleine, leur procede de preparation et leur application en therapeutique.
|
DE4140519A1
(de)
*
|
1991-12-09 |
1993-06-17 |
Merck Patent Gmbh |
Benzofurane
|
DE4141788A1
(de)
*
|
1991-12-18 |
1993-06-24 |
Merck Patent Gmbh |
Imidazopyridine
|
ATE190058T1
(de)
*
|
1991-12-27 |
2000-03-15 |
Kyowa Hakko Kogyo Kk |
Tricyclische verbindungen als angiotensin-ii- antagonisten
|
US5378701A
(en)
*
|
1991-12-27 |
1995-01-03 |
Kyowa Hakko Kogyo |
Tricyclic compounds
|
GB9201715D0
(en)
*
|
1992-01-28 |
1992-03-11 |
Ici Plc |
Chemical process
|
GB2263637A
(en)
*
|
1992-01-28 |
1993-08-04 |
Merck & Co Inc |
Substituted imidazo-fused 6-membered carbocycle or heterocycle as neurotensin antagonists
|
US5312958A
(en)
*
|
1992-01-31 |
1994-05-17 |
Takeda Chemical Industries, Ltd. |
Process for producing 4-bromomethylbiphenyl compounds
|
FR2687677B1
(fr)
*
|
1992-02-24 |
1996-10-11 |
Union Pharma Scient Appl |
Nouveaux derives de polyazaindenes antagonistes des recepteurs a l'angiotensine ii ; leurs procedes de preparation, compositions pharmaceutiques les contenant.
|
WO1993018030A1
(en)
*
|
1992-03-03 |
1993-09-16 |
Fujisawa Pharmaceutical Co., Ltd. |
Benzimidazole derivatives as angiotensin ii antagonists
|
US5208235A
(en)
*
|
1992-03-10 |
1993-05-04 |
E. R. Squibb & Sons, Inc. |
Indole- and benzimidazole-substituted imidazole derivatives
|
US5208234A
(en)
*
|
1992-03-10 |
1993-05-04 |
E. R. Squibb & Sons, Inc. |
Substituted imidazole phosphonic and phosphinic acid derivatives
|
DE4208304A1
(de)
*
|
1992-03-16 |
1993-09-23 |
Merck Patent Gmbh |
2-oxochinolinderivate
|
EP0602246A4
(en)
*
|
1992-03-25 |
1995-07-05 |
Green Cross Corp |
ISOINDAZOLE COMPOUND.
|
US5478832A
(en)
*
|
1992-05-08 |
1995-12-26 |
The Green Cross Corporation |
Quinoline compounds
|
CN1039714C
(zh)
*
|
1992-05-13 |
1998-09-09 |
森得克斯(美国)股份有限公司 |
取代吲哚衍生物、它的制备方法及其应用
|
DE4305602A1
(de)
*
|
1992-06-17 |
1993-12-23 |
Merck Patent Gmbh |
Imidazopyridine
|
FR2693197B1
(fr)
*
|
1992-07-03 |
1994-09-23 |
Synthelabo |
Nouveaux dérivés de quinoléine, leur procédé de préparation et leur application thérapeutique.
|
GB9218449D0
(en)
|
1992-08-29 |
1992-10-14 |
Boots Co Plc |
Therapeutic agents
|
WO1994001436A1
(en)
*
|
1992-07-10 |
1994-01-20 |
The Boots Company Plc |
Dioxcyclobutene derivatives as angiotensin ii antagonists
|
EP0668864A1
(en)
*
|
1992-07-17 |
1995-08-30 |
Merck & Co. Inc. |
Substituted biphenylmethylimidazopyridines
|
DE4225835A1
(de)
*
|
1992-08-05 |
1994-02-10 |
Merck Patent Gmbh |
Verfahren zur Herstellung von Imidazopyridinen
|
US5359073A
(en)
*
|
1992-11-24 |
1994-10-25 |
G. D. Searle & Co. |
Substituted-phenyl (N,N'-cycloalkyl/alkyl carboxamide)-1H/3H-imidazo[4,5-b]pyridine compounds as PAF antagonists
|
US5376666A
(en)
*
|
1992-11-30 |
1994-12-27 |
The Du Pont Merck Pharmaceutical Company |
Angiotension-II receptor blocking, azacycloalkyl or azacycloalkenyl
|
WO1994013666A1
(en)
*
|
1992-12-07 |
1994-06-23 |
Eisai Co., Ltd. |
Process for producing imidazopyridine derivative and intermediate
|
DE4242459A1
(de)
*
|
1992-12-16 |
1994-06-23 |
Merck Patent Gmbh |
Imidazopyridine
|
JP3501484B2
(ja)
*
|
1992-12-17 |
2004-03-02 |
三共株式会社 |
ビフェニル誘導体
|
IT1263804B
(it)
*
|
1993-01-22 |
1996-09-03 |
Luso Farmaco Inst |
Derivati pirimidinonici fusi con eterocicli azotati ad attivita' a ii antagonista
|
DE4302956A1
(de)
*
|
1993-02-03 |
1994-08-04 |
Bayer Ag |
Substituierte Imidazo(4,5-b)pyridine und Benzimidazole
|
US5491172A
(en)
*
|
1993-05-14 |
1996-02-13 |
Warner-Lambert Company |
N-acyl sulfamic acid esters (or thioesters), N-acyl sulfonamides, and N-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents
|
IL109431A
(en)
*
|
1993-05-14 |
2001-01-11 |
Warner Lambert Co |
Pharmaceutical compositions containing n-acyl sulfamic acid esters (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters), for regulating plasma cholesterol concentration, and certain such novel compounds
|
DE4318813A1
(de)
*
|
1993-06-07 |
1994-12-08 |
Merck Patent Gmbh |
Imidazopyridine
|
US5571813A
(en)
*
|
1993-06-10 |
1996-11-05 |
Beiersdorf-Lilly Gmbh |
Fused pyrimidine compounds and their use as pharmaceuticals
|
EP0628559B1
(en)
*
|
1993-06-10 |
2002-04-03 |
Beiersdorf-Lilly GmbH |
Pyrimidine compounds and their use as pharmaceuticals
|
DE4320432A1
(de)
*
|
1993-06-21 |
1994-12-22 |
Bayer Ag |
Substituierte Mono- und Bipyridylmethylderivate
|
US5338740A
(en)
*
|
1993-07-13 |
1994-08-16 |
Pfizer Inc. |
Angiotensin II receptor antagonists
|
DE4339868A1
(de)
*
|
1993-11-23 |
1995-05-24 |
Merck Patent Gmbh |
Imidazopyridazine
|
DE4341453A1
(de)
*
|
1993-12-06 |
1995-06-08 |
Merck Patent Gmbh |
Imidazopyridine
|
KR0151816B1
(ko)
*
|
1994-02-08 |
1998-10-15 |
강박광 |
신규의 치환된 피리딜 이미다졸 유도체 및 그의 제조방법
|
ES2079315B1
(es)
*
|
1994-02-24 |
1996-10-16 |
Uriach & Cia Sa J |
Nuevas imidazopiridinas.
|
KR0151819B1
(ko)
*
|
1994-06-11 |
1998-10-15 |
강박광 |
신규의 피리딜 n-옥사이드로 치환된 피디딜이미다졸 유도체 및 그의 제조방법
|
DE4432860A1
(de)
*
|
1994-09-15 |
1996-03-21 |
Merck Patent Gmbh |
Imidazopyridine
|
JP2002507996A
(ja)
*
|
1997-07-03 |
2002-03-12 |
デュポン ファーマシューティカルズ カンパニー |
神経学的障害を治療するためのイミダゾピリミジン類およびイミダゾピリジン類
|
US6365589B1
(en)
|
1998-07-02 |
2002-04-02 |
Bristol-Myers Squibb Pharma Company |
Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonists
|
US6124463A
(en)
*
|
1998-07-02 |
2000-09-26 |
Dupont Pharmaceuticals |
Benzimidazoles as corticotropin release factor antagonists
|
AU767456B2
(en)
*
|
1998-07-06 |
2003-11-13 |
Bristol-Myers Squibb Company |
Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
|
US6638937B2
(en)
|
1998-07-06 |
2003-10-28 |
Bristol-Myers Squibb Co. |
Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
|
AU758789B2
(en)
|
1998-07-15 |
2003-03-27 |
Teijin Limited |
Thiobenzimidazole derivatives
|
TW526202B
(en)
*
|
1998-11-27 |
2003-04-01 |
Shionogi & Amp Co |
Broad spectrum cephem having benzo[4,5-b]pyridium methyl group of antibiotic activity
|
SE9903028D0
(sv)
|
1999-08-27 |
1999-08-27 |
Astra Ab |
New use
|
AR037097A1
(es)
|
2001-10-05 |
2004-10-20 |
Novartis Ag |
Compuestos acilsulfonamidas, composiciones farmaceuticas y el uso de dichos compuestos para la preparacion de un medicamento
|
JP4491344B2
(ja)
|
2002-06-17 |
2010-06-30 |
グラクソ グループ リミテッド |
肝x受容体アゴニストとしてのプリン誘導体
|
US7569574B2
(en)
|
2002-08-22 |
2009-08-04 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Purine derivatives, the preparation thereof and their use as pharmaceutical compositions
|
US7495005B2
(en)
|
2002-08-22 |
2009-02-24 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Xanthine derivatives, their preparation and their use in pharmaceutical compositions
|
US7482337B2
(en)
|
2002-11-08 |
2009-01-27 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions
|
DE10254304A1
(de)
|
2002-11-21 |
2004-06-03 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Xanthinderivate, deren Herstellung und deren Verwendung als Arzneimittel
|
US7566707B2
(en)
|
2003-06-18 |
2009-07-28 |
Boehringer Ingelheim International Gmbh |
Imidazopyridazinone and imidazopyridone derivatives, the preparation thereof and their use as pharmaceutical compositions
|
DE10355304A1
(de)
|
2003-11-27 |
2005-06-23 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue 8-(Piperazin-1-yl)-und 8-([1,4]Diazepan-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
|
US7501426B2
(en)
|
2004-02-18 |
2009-03-10 |
Boehringer Ingelheim International Gmbh |
8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
|
DE102004009039A1
(de)
|
2004-02-23 |
2005-09-08 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
8-[3-Amino-piperidin-1-yl]-xanthine, deren Herstellung und Verwendung als Arzneimittel
|
US7393847B2
(en)
|
2004-03-13 |
2008-07-01 |
Boehringer Ingleheim International Gmbh |
Imidazopyridazinediones, their preparation and their use as pharmaceutical compositions
|
US7439370B2
(en)
|
2004-05-10 |
2008-10-21 |
Boehringer Ingelheim International Gmbh |
Imidazole derivatives, their preparation and their use as intermediates for the preparation of pharmaceutical compositions and pesticides
|
RU2007101509A
(ru)
|
2004-06-17 |
2008-07-27 |
Уайт (Us) |
Способ получения антагонистов рецепторов гормона, высвобождающего гонадотропин
|
BRPI0512261A
(pt)
|
2004-06-17 |
2008-02-26 |
Wyeth Corp |
antagonistas de receptor de hormÈnio liberador de gonadotropina
|
DE102004030502A1
(de)
|
2004-06-24 |
2006-01-12 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Imidazole und Triazole, deren Herstellung und Verwendung als Arzneimittel
|
DE102004043944A1
(de)
|
2004-09-11 |
2006-03-30 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue 8-(3-Amino-piperidin-1-yl)-7-(but-2-inyl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
|
DE102004044221A1
(de)
|
2004-09-14 |
2006-03-16 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue 3-Methyl-7-butinyl-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
|
DE102004054054A1
(de)
|
2004-11-05 |
2006-05-11 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
|
US7582634B2
(en)
|
2005-02-18 |
2009-09-01 |
Wyeth |
7-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor
|
US7538113B2
(en)
|
2005-02-18 |
2009-05-26 |
Wyeth |
4-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor
|
US7534796B2
(en)
|
2005-02-18 |
2009-05-19 |
Wyeth |
Imidazo[4,5-b]pyridine antagonists of gonadotropin releasing hormone receptor
|
US7531542B2
(en)
|
2005-05-18 |
2009-05-12 |
Wyeth |
Benzooxazole and benzothiazole antagonists of gonadotropin releasing hormone receptor
|
US7582636B2
(en)
|
2005-05-26 |
2009-09-01 |
Wyeth |
Piperazinylimidazopyridine and piperazinyltriazolopyridine antagonists of Gonadotropin Releasing Hormone receptor
|
DE102005035891A1
(de)
|
2005-07-30 |
2007-02-08 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
|
EP1852108A1
(en)
|
2006-05-04 |
2007-11-07 |
Boehringer Ingelheim Pharma GmbH & Co.KG |
DPP IV inhibitor formulations
|
CA2873524C
(en)
|
2006-05-04 |
2018-02-20 |
Boehringer Ingelheim International Gmbh |
A polymeric form of 1-((4-methyl-quinazolin-2-yl)methyl)-3-7-(2-butyn-1-yl)-8-(3-(r)-aminopiperidin-1-yl)xanthine
|
PE20110235A1
(es)
|
2006-05-04 |
2011-04-14 |
Boehringer Ingelheim Int |
Combinaciones farmaceuticas que comprenden linagliptina y metmorfina
|
CA2660197A1
(en)
|
2006-08-08 |
2008-02-14 |
Boehringer Ingelheim International Gmbh |
Pyrrolo[3,2-d]pyrimidines as dpp-iv inhibitors for the treatment of diabetes mellitus
|
US8969514B2
(en)
|
2007-06-04 |
2015-03-03 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
|
DK2170930T3
(da)
|
2007-06-04 |
2012-11-05 |
Synergy Pharmaceuticals Inc |
Agonister af guanylatcyclase, anvendelige til behandlingen af gastrointestinale sygdomme, inflammation, cancer og andre sygdomme
|
JP2011522828A
(ja)
|
2008-06-04 |
2011-08-04 |
シナジー ファーマシューティカルズ インコーポレイテッド |
胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト
|
JP2011526881A
(ja)
*
|
2008-06-25 |
2011-10-20 |
ファイザー・インク |
ジアリール化合物およびそれらの使用
|
ES2624828T3
(es)
|
2008-07-16 |
2017-07-17 |
Synergy Pharmaceuticals Inc. |
Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
|
UY32030A
(es)
|
2008-08-06 |
2010-03-26 |
Boehringer Ingelheim Int |
"tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
|
BRPI0916997A2
(pt)
|
2008-08-06 |
2020-12-15 |
Boehringer Ingelheim International Gmbh |
Inibidor de dpp-4 e seu uso
|
CN102149407A
(zh)
|
2008-09-10 |
2011-08-10 |
贝林格尔.英格海姆国际有限公司 |
治疗糖尿病和相关病症的组合疗法
|
US20200155558A1
(en)
|
2018-11-20 |
2020-05-21 |
Boehringer Ingelheim International Gmbh |
Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
|
BRPI0923121A2
(pt)
|
2008-12-23 |
2015-08-11 |
Boehringer Ingelheim Int |
Formas salinas de compostos orgânico
|
AR074990A1
(es)
|
2009-01-07 |
2011-03-02 |
Boehringer Ingelheim Int |
Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina
|
KR101117128B1
(ko)
*
|
2009-06-02 |
2012-03-14 |
한국화학연구원 |
페닐테트라졸 유도체 또는 이의 약학적으로 허용가능한 염을 유효성분으로 포함하는 골다공증 또는 비만의 예방 또는 치료용 약학적 조성물
|
US8372862B2
(en)
|
2009-06-02 |
2013-02-12 |
Korea Research Institute Of Chemical Technology |
Pharmaceutical composition for preventing or treating osteoporosis or obesity comprising phenyltetrazole derivative
|
CN102753161A
(zh)
|
2009-11-27 |
2012-10-24 |
贝林格尔.英格海姆国际有限公司 |
基因型糖尿病患者利用dpp-iv抑制剂例如利拉利汀的治疗
|
WO2011138421A1
(en)
|
2010-05-05 |
2011-11-10 |
Boehringer Ingelheim International Gmbh |
Combination therapy
|
EP2571878B1
(en)
*
|
2010-05-17 |
2018-10-17 |
Incozen Therapeutics Pvt. Ltd. |
Novel 3,5-disubstitued-3h-imidazo[4,5-b]pyridine and 3,5- disubstitued -3h-[1,2,3]triazolo[4,5-b]pyridine compounds as modulators of protein kinases
|
EP3124041A1
(en)
|
2010-06-24 |
2017-02-01 |
Boehringer Ingelheim International GmbH |
Diabetes therapy
|
US9616097B2
(en)
|
2010-09-15 |
2017-04-11 |
Synergy Pharmaceuticals, Inc. |
Formulations of guanylate cyclase C agonists and methods of use
|
AR083878A1
(es)
|
2010-11-15 |
2013-03-27 |
Boehringer Ingelheim Int |
Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento
|
WO2013011932A1
(ja)
|
2011-07-15 |
2013-01-24 |
塩野義製薬株式会社 |
Ampk活性化作用を有するアザベンズイミダゾール誘導体
|
ES2713566T3
(es)
|
2011-07-15 |
2019-05-22 |
Boehringer Ingelheim Int |
Derivado de quinazolina dimérico sustituido, su preparación y su uso en composiciones farmacéuticas para el tratamiento de la diabetes de tipo I y II
|
US9555001B2
(en)
|
2012-03-07 |
2017-01-31 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical composition and uses thereof
|
WO2013171167A1
(en)
|
2012-05-14 |
2013-11-21 |
Boehringer Ingelheim International Gmbh |
A xanthine derivative as dpp -4 inhibitor for use in the treatment of podocytes related disorders and/or nephrotic syndrome
|
WO2013174767A1
(en)
|
2012-05-24 |
2013-11-28 |
Boehringer Ingelheim International Gmbh |
A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
|
AU2014235209B2
(en)
|
2013-03-15 |
2018-06-14 |
Bausch Health Ireland Limited |
Guanylate cyclase receptor agonists combined with other drugs
|
US9708367B2
(en)
|
2013-03-15 |
2017-07-18 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase and their uses
|
KR102272746B1
(ko)
|
2013-06-05 |
2021-07-08 |
보슈 헬스 아일랜드 리미티드 |
구아닐레이트 사이클라제 c의 초순수 작용제, 및 이의 제조 및 사용 방법
|
GB201321741D0
(en)
*
|
2013-12-09 |
2014-01-22 |
Ucb Pharma Sa |
Therapeutic agents
|
ES2950384T3
(es)
|
2014-02-28 |
2023-10-09 |
Boehringer Ingelheim Int |
Uso médico de un inhibidor de DPP-4
|
JP2019517542A
(ja)
|
2016-06-10 |
2019-06-24 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
リナグリプチンおよびメトホルミンの組合せ
|
JP7231414B2
(ja)
|
2016-06-29 |
2023-03-01 |
ユニヴェルシテ・ドゥ・モントリオール |
ビアリールメチルヘテロサイクル
|